Deletion or inhibition of Fc gamma receptor 2B (CD32) prevents FVIII-specific activation of memory B cells in vitro

Thrombosis and Haemostasis

Volumn 114, Issue 6, 2015, Pages 1127-1135

  Werwitzke, Sonja ^a   Vollack, Nadine ^a   von Hornung, Marcus ^a   Kalippke, Katy ^a   Kutzschbach, Julia ^a   Trummer, Arne ^a   Ganser, Arnold ^a   Tiede, Andreas ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

CD32; Haemophilia A mouse model; Inhibitor; Memory B cells; Recall Response

Indexed keywords

BLOOD CLOTTING FACTOR 8; CD32 ANTIGEN; FC RECEPTOR IIB; ANTIGEN ANTIBODY COMPLEX; CD45 ANTIGEN; F8 PROTEIN, HUMAN; FC RECEPTOR; FCGR2B PROTEIN, MOUSE; HETEROPHILE ANTIBODY; MONOCLONAL ANTIBODY; NEUTRALIZING ANTIBODY; RECOMBINANT PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY SECRETING CELL; ANTIGEN ANTIBODY COMPLEX; APOPTOSIS; ARTICLE; CELL ACTIVATION; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; ENZYME LINKED IMMUNOSPOT ASSAY; FLOW CYTOMETRY; HEMOPHILIA A; IMMUNE RESPONSE; LYMPHOCYTE PROLIFERATION; MEMORY CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; ADOPTIVE TRANSFER; ANALYSIS; ANIMAL; ANTAGONISTS AND INHIBITORS; B LYMPHOCYTE; BIOSYNTHESIS; BONE MARROW; CELL CULTURE; DEFICIENCY; DISEASE MODEL; DOSE RESPONSE; DRUG EFFECTS; GENETICS; IMMUNOLOGICAL MEMORY; IMMUNOLOGY; KNOCKOUT MOUSE; LYMPHOCYTE ACTIVATION; PHYSIOLOGY; SPLEEN;

ADOPTIVE TRANSFER; ANIMALS; ANTIBODIES, HETEROPHILE; ANTIBODIES, MONOCLONAL; ANTIBODIES, NEUTRALIZING; ANTIGEN-ANTIBODY COMPLEX; ANTIGENS, CD45; APOPTOSIS; B-LYMPHOCYTE SUBSETS; BONE MARROW; CELLS, CULTURED; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, IMMUNOLOGIC; FACTOR VIII; HEMOPHILIA A; IMMUNOLOGIC MEMORY; LYMPHOCYTE ACTIVATION; MICE; MICE, KNOCKOUT; RECEPTORS, IGG; RECOMBINANT PROTEINS; SPLEEN;

EID: 84983094907     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1160/TH14-06-0535     Document Type: Article

References (32)

1. Witmer C, Young G. Factor VIII inhibitors in hemophilia A: rationale and latest evidence. Ther Adv Hematol 2013; 4: 59-72.
2. Pratt KP. Inhibitory antibodies in hemophilia A. Curr Opin Hematol 2012; 19: 399-405.
3. Hay CR, DiMichele DM, International Immune Tolerance S. The principal results of the International Immune Tolerance Study: a randomized dose comparison. Blood 2012; 119: 1335-1344.
4. DiMichele DM. Immune tolerance in haemophilia: the long journey to the fork in the road. Br J Haematol 2012; 159: 123-134.
5. Kempton CL, White GC, 2nd. How we treat a hemophilia A patient with a factor VIII inhibitor. Blood 2009; 113: 11-17.
6. Hausl C, Ahmad RU, Schwarz HP, et al. Preventing restimulation of memory B cells in hemophilia A: a potential new strategy for the treatment of antibody-dependent immune disorders. Blood 2004; 104: 115-122.
7. Hausl C, Ahmad RU, Sasgary M, et al. High-dose factor VIII inhibits factor VIII-specific memory B cells in hemophilia A with factor VIII inhibitors. Blood 2005; 106: 3415-3422.
8. Reipert BM, Allacher P, Hausl C, et al. Modulation of factor VIII-specific memory B cells. Haemophilia 2010; 16: 25-34.
9. Berard M, Casamayor-Palleja M, Billian G, et al. Activation sensitizes human memory B cells to B-cell receptor-induced apoptosis. Immunology 1999; 98: 47-54.
10. Gessner JE, Heiken H, Tamm A, et al. The IgG Fc receptor family. Ann Hematol 1998; 76: 231-248.
11. Qin D, Wu J, Vora KA, et al. Fc gamma receptor IIB on follicular dendritic cells regulates the B cell recall response. J Immunol 2000; 164: 6268-6275.
12. Nimmerjahn F, Ravetch JV. Fcgamma receptors as regulators of immune responses. Nat Rev Immunol 2008; 8: 34-47.
13. Takai T, Ono M, Hikida M, et al. Augmented humoral and anaphylactic responses in Fc gamma RII-deficient mice. Nature 1996; 379: 346-349.
14. Bolland S, Ravetch JV. Spontaneous autoimmune disease in Fc(gamma)RIIBdeficient mice results from strain-specific epistasis. Immunity 2000; 13: 277-285.
15. Clynes R, Maizes JS, Guinamard R, et al. Modulation of immune complex-induced inflammation in vivo by the coordinate expression of activation and inhibitory Fc receptors. J Exp Med 1999; 189: 179-185.
16. Li J, Tuzun E, Wu XR, et al. Inhibitory IgG receptor FcgammaRIIB fails to inhibit experimental autoimmune myasthenia gravis pathogenesis. J Neuroimmunol 2008; 194: 44-53.
17. Bi L, Lawler AM, Antonarakis SE, et al. Targeted disruption of the mouse factor VIII gene produces a model of haemophilia A. Nat Genet 1995; 10: 119-121.
18. Bi L, Sarkar R, Naas T, et al. Further characterisation of factor VIII-deficient mice created by gene targeting: RNA and protein studies. Blood 1996; 88: 3446-3450.
19. Qian J, Borovok M, Bi L, et al. Inhibitor antibody development and T cell response to human factor VIII in murine hemophilia A. Thromb Haemost 1999; 81: 240-244.
20. Reipert BM, Ahmad RU, Turecek PL, et al. Characterisation of antibodies induced by human factor VIII in a murine knockout model of hemophilia A. Thromb Haemost 2000; 84: 826-832.
21. Hausl C, Maier E, Schwarz HP, et al. Long-term persistence of anti-factor VIII antibody-secreting cells in hemophilic mice after treatment with human factor VIII. Thromb Haemost 2002; 87: 840-845.
22. Sasgary M, Ahmad RU, Schwarz HP, et al. Single cell analysis of factor VIII-specific T cells in hemophilic mice after treatment with human factor VIII. Thromb Haemost 2002; 87: 266-272.
23. Kalippke K, Werwitzke S, von Hornung M, et al. DNA analysis from stool samples: a fast and reliable method avoiding invasive sampling methods in mouse models of bleeding disorders. Lab Anim 2009; 43: 390-393.
24. Sondermann P, Huber R, Oosthuizen V, et al. The 3.2-A crystal structure of the human IgG1 Fc fragment-Fc gammaRIII complex. Nature 2000; 406: 267-273.
25. Werwitzke S, Trick D, Sondermann P, et al. Treatment of lupus-prone NZB/ NZW F1 mice with recombinant soluble Fc gamma receptor II (CD32). Ann Rheum Dis 2008; 67: 154-161.
26. Tomayko MM, Steinel NC, Anderson SM, et al. Cutting edge: Hierarchy of maturity of murine memory B cell subsets. J Immunol 2010; 185: 7146-7150.
27. Zuccarino-Catania GV, Sadanand S, Weisel FJ, et al. CD80 and PD-L2 define functionally distinct memory B cell subsets that are independent of antibody isotype. Nat Immunol 2014; 15: 631-637.
28. Hausl C vHP, Ahmad RU, Muchitsch EM, et al. The Relevance of the Inhibitory Receptor FcgIIB for the Regulation of Anti-Factor VIII Antibody Response in Murine Models. Blood (ASH Annual Meeting Abstracts); November 2007: 110, Abstract 785.
29. Nakamura A, Yuasa T, Ujike A, et al. Fcgamma receptor IIB-deficient mice develop Goodpasture’s syndrome upon immunisation with type IV collagen: a novel murine model for autoimmune glomerular basement membrane disease. J Exp Med 2000; 191: 899-906.
30. Boross P, Arandhara VL, Martin-Ramirez J, et al. The inhibiting Fc receptor for IgG, FcgammaRIIB, is a modifier of autoimmune susceptibility. J Immunol 2011; 187: 1304-1313.
31. Williams EL, Tutt AL, French RR, et al. Development and characterisation of monoclonal antibodies specific for the murine inhibitory FcgammaRIIB (CD32B). Eur J Immunol 2012; 42: 2109-2120.
32. Zhang AH, Skupsky J, Scott DW. Effect of B-cell depletion using anti-CD20 therapy on inhibitory antibody formation to human FVIII in hemophilia A mice. Blood 2011; 117: 2223-2226.